n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Author(s) -
Maria Carla Roncaglioni,
Massimo Tombesi,
Fausto Avanzini,
Simona Barlera,
Vittorio Caimi,
Paolo Longoni,
Irene Marzona,
Valentina Milani,
Maria Giuseppina Silletta,
Gianni Togi,
Roberto Marchioli
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1205409
Subject(s) - medicine , myocardial infarction , hazard ratio , clinical endpoint , placebo , stroke (engine) , cardiology , confidence interval , polyunsaturated fatty acid , surgery , randomized controlled trial , fatty acid , pathology , mechanical engineering , chemistry , alternative medicine , organic chemistry , engineering
Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previous myocardial infarction or heart failure. We evaluated the potential benefit of such therapy in patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who had not had a myocardial infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom